John Shook, MD
Surgical Oncology · Kansas City, MONPI 1215976915
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (32.0%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Molli Surgical (US) Inc at 54.9% of the total. Reporting peaked in 2023 at $1,672 and has fallen 91.1% since, to $149 in 2024.
Across 23 payments — averaging $173.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Molli Surgical (US) Inc$2K
- Medtronic$851
- Hologic Inc$637
- W. L. Gore & Associates, Inc.$141
- Endomagnetics Ltd$136
- Sirius Medical Systems$24
- plus $13 from 1 others
What the payments were for
- Consulting fees$80020%
- Speaking & faculty fees$75019%
- Travel & lodging$1,27932%
- Food & beverage$1,16529%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Molli Surgical (US) Inc | 6 | $2,192 |
| Medtronic | 9 | $851 |
| Hologic Inc | 2 | $637 |
| W. L. Gore & Associates, Inc. | 2 | $141 |
| Endomagnetics Ltd | 2 | $136 |
| Sirius Medical Systems | 1 | $24 |
| Hologic Sales And Service, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PlasmaBlade$677
- BioZorb$534
- Magseed$126
- Magtrace$126
- GORE ENFORM Preperitoneal Biomaterial$120
- Localizer$103
How this compares
$3,994 in reported general payments places this provider in the 55th percentile of 24 surgical oncology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $171 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Kansas City
- Peter DipascoSaint Louis$247K
- Trang NguyenSaint Louis$11K
- Rebecca AftSaint Louis$9K
- Ana Belzarena GenoveseColumbia$8K
- Julie MargenthalerSaint Louis$8K
- Charles WoodallSpringfield$7K
- Aislinn VaughanSaint Charles$7K
- Eric KimchiColumbia$5K
- Taylor BrownSaint Louis$5K
- Timothy VreelandSaint Louis$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.